Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peptide Elongation Factors | 4 | 2005 | 28 | 0.570 |
Why?
|
| Proto-Oncogenes | 4 | 2005 | 61 | 0.540 |
Why?
|
| Transcription Factors | 7 | 2007 | 1565 | 0.520 |
Why?
|
| DNA-Binding Proteins | 6 | 2005 | 1208 | 0.430 |
Why?
|
| Neoplasm Proteins | 4 | 2005 | 532 | 0.320 |
Why?
|
| Transcriptional Elongation Factors | 6 | 2007 | 23 | 0.280 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2003 | 128 | 0.270 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2005 | 12 | 0.260 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2005 | 72 | 0.190 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2005 | 154 | 0.170 |
Why?
|
| Transfection | 4 | 2007 | 896 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2005 | 557 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2002 | 2062 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 3030 | 0.080 |
Why?
|
| HeLa Cells | 3 | 2007 | 498 | 0.080 |
Why?
|
| Apoptosis | 2 | 2007 | 1683 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2003 | 763 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2002 | 256 | 0.070 |
Why?
|
| COS Cells | 1 | 2005 | 166 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2001 | 351 | 0.060 |
Why?
|
| Coiled Bodies | 1 | 2003 | 2 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2002 | 427 | 0.060 |
Why?
|
| Immunosorbent Techniques | 1 | 2002 | 13 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2002 | 28 | 0.060 |
Why?
|
| Binding Sites | 2 | 2002 | 1098 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2002 | 64 | 0.060 |
Why?
|
| Serine | 1 | 2002 | 99 | 0.050 |
Why?
|
| Retroviridae | 1 | 2002 | 79 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2002 | 152 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2002 | 56 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2002 | 210 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 108 | 0.050 |
Why?
|
| Animals | 5 | 2005 | 26582 | 0.050 |
Why?
|
| Mice | 4 | 2002 | 11352 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2002 | 435 | 0.050 |
Why?
|
| Protein Binding | 2 | 2002 | 1456 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2002 | 460 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2002 | 292 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1753 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2002 | 579 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2002 | 504 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 280 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 1135 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1041 | 0.040 |
Why?
|
| Leukemia | 1 | 2001 | 320 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2002 | 403 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 645 | 0.040 |
Why?
|
| Proteins | 1 | 2002 | 777 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1920 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1721 | 0.030 |
Why?
|
| Mutation | 1 | 2005 | 3968 | 0.030 |
Why?
|
| Humans | 6 | 2007 | 86643 | 0.030 |
Why?
|
| Cell Line | 2 | 2003 | 2468 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2007 | 26 | 0.020 |
Why?
|
| snRNP Core Proteins | 1 | 2003 | 9 | 0.010 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2003 | 20 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2003 | 106 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2003 | 59 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2003 | 58 | 0.010 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2002 | 5 | 0.010 |
Why?
|
| Autoantigens | 1 | 2003 | 127 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2002 | 64 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2002 | 43 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2003 | 265 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2002 | 129 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 118 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 254 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 303 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 268 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2426 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1014 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 199 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 1578 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 636 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 1047 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 560 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 937 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 853 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 696 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 1284 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 724 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 1384 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2818 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 1197 | 0.010 |
Why?
|
| Male | 1 | 2007 | 40965 | 0.000 |
Why?
|